Dual ablation of FABP4 and FABP5 was shown to protect from metabolic disorders including insulin resistance, fatty liver, and atherosclerosis more than does a single deficiency of FABP4 or that of FABP5 in mouse models (4, 5, 44–46). This evidence concerns the gene FABP5 and metabolic disease.